Left ventricular assist device

From Citizendium
Revision as of 19:27, 2 October 2013 by imported>Meg Taylor
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

A left ventricular assist device or LVAD is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for bridge to transplant (BTT) or destination therapy (DT). Currently, the top three companies in this field are:

  1. Thoratec - Heartmate2 market capital $2B US
  2. Ventracor - VentrAssist
  3. Heartware